用于无创成像整合素α(v)β3阳性乳腺癌的(99m)Tc标记环状RGD四聚体的评估

Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.

作者信息

Liu Shuang, Hsieh Wen-Yuan, Jiang Young, Kim Young-Seung, Sreerama Subramanya G, Chen Xiaoyuan, Jia Bing, Wang Fan

机构信息

School of Health Sciences, Purdue University, West Lafayette, Indiana 47907-2051, USA.

出版信息

Bioconjug Chem. 2007 Mar-Apr;18(2):438-46. doi: 10.1021/bc0603081. Epub 2007 Mar 7.

Abstract

Integrin alphavbeta3 plays a critical role in tumor angiogenesis and metastasis. Radiolabeled RGD peptides that are integrin alphavbeta3-specific are very useful for noninvasive imaging of integrin expression in rapidly growing and metastatic tumors. In this study, we determined the binding affinity of E{E[c(RGDfK)]2}2 (tetramer) and its 6-hydrazinonicotinamide conjugate (HYNIC-tetramer) against the binding of 125I-echistatin to the integrin alphavbeta3-positive MDA-MB-435 breast cancer cells. The athymic nude mice bearing MDA-MB-435 xenografts were used to evaluate the potential of ternary ligand complex [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] (TPPTS = trisodium triphenylphosphine-3,3',3' '-trisulfonate) as a new radiotracer for imaging breast cancer integrin alphavbeta3 expression by single photon emission computed tomography (SPECT). It was found that the binding affinity of tetramer (IC50 = 51 +/- 11 nM) was slightly higher than that of its dimeric analogue (IC50 = 78 +/- 27 nM) and is comparable to that of the HYNIC-tetramer conjugate (IC50 = 55 +/- 11 nM) within the experimental error. Biodistribution data showed that [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] had a rapid blood clearance (4.61 +/- 0.81 %ID/g at 5 min postinjection (p.i.) and 0.56 +/- 0.12 %ID/g at 120 min p.i.) and was excreted mainly via the renal route. [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] had high tumor uptake with a long tumor retention (5.60 +/- 0.87 %ID/g and 7.30 +/- 1.32 %ID/g at 5 and 120 min p.i., respectively). The integrin alphavbeta3-specificity was demonstrated by co-injection of excess E[c(RGDfK)]2, which resulted in a significant reduction in tumor uptake of the radiotracer. The metabolic stability of [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] was determined by analyzing urine and feces samples from the tumor-bearing mice at 120 min p.i. In the urine, about 20% of [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] remained intact while only approximately 15% metabolized species was detected in feces. SPECT images displayed significant radiotracer localization in tumor with good contrast as early as 1 h p.i. The high tumor uptake and fast renal excretion make [99mTc(HYNIC-tetramer)(tricine)(TPPTS)] a promising radiotracer for noninvasive imaging of the integrin alphavbeta3-positive tumors by SPECT.

摘要

整合素αvβ3在肿瘤血管生成和转移中起关键作用。对整合素αvβ3具有特异性的放射性标记RGD肽对于快速生长和转移性肿瘤中整合素表达的无创成像非常有用。在本研究中,我们测定了E{E[c(RGDfK)]2}2(四聚体)及其6-肼基烟酰胺缀合物(HYNIC-四聚体)对125I-echistatin与整合素αvβ3阳性的MDA-MB-435乳腺癌细胞结合的竞争亲和力。使用携带MDA-MB-435异种移植瘤的无胸腺裸鼠来评估三元配体复合物[99mTc(HYNIC-四聚体)(tricine)(TPPTS)](TPPTS = 三苯基膦-3,3',3''-三磺酸钠)作为通过单光子发射计算机断层扫描(SPECT)成像乳腺癌整合素αvβ3表达的新型放射性示踪剂的潜力。结果发现,四聚体的结合亲和力(IC50 = 51±11 nM)略高于其二聚体类似物(IC50 = 78±27 nM),并且在实验误差范围内与HYNIC-四聚体缀合物(IC50 = 55±11 nM)相当。生物分布数据表明,[99mTc(HYNIC-四聚体)(tricine)(TPPTS)]具有快速的血液清除率(注射后5分钟(p.i.)为4.61±0.81 %ID/g,注射后120分钟为0.56±0.12 %ID/g),主要通过肾脏途径排泄。[99mTc(HYNIC-四聚体)(tricine)(TPPTS)]具有高肿瘤摄取和长时间的肿瘤滞留(注射后5分钟和120分钟分别为5.60±0.87 %ID/g和7.30±1.32 %ID/g)。通过共同注射过量的E[c(RGDfK)]2证明了整合素αvβ3的特异性,这导致放射性示踪剂的肿瘤摄取显著降低。通过分析注射后120分钟时荷瘤小鼠的尿液和粪便样本,测定了[99mTc(HYNIC-四聚体)(tricine)(TPPTS)]的代谢稳定性。在尿液中,约20%的[99mTc(HYNIC-四聚体)(tricine)(TPPTS)]保持完整,而在粪便中仅检测到约15%的代谢产物。SPECT图像显示,早在注射后1小时,放射性示踪剂就在肿瘤中显著定位,对比度良好。高肿瘤摄取和快速肾脏排泄使[99mTc(HYNIC-四聚体)(tricine)(TPPTS)]成为通过SPECT对整合素αvβ3阳性肿瘤进行无创成像的有前景的放射性示踪剂。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索